{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q07812",
      "entity_text" : "Bax",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01619",
      "entity_text" : "AAP10",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Compared with PFD pre-treatment, the Cx43 agonist, AAP10, also increased the mRNA ratio of Bax / Bcl-2, and increased the mRNA expression levels of cleaved caspase-3 and Cx43 (XREF_FIG).",
  "reading_complete" : "2020-08-03T13:35:47Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T13:35:04Z",
  "trigger" : "increased",
  "evidence" : [ "AAP10, also increased the mRNA ratio of Bax" ],
  "pmc_id" : "7053877",
  "score" : 0
}